Alex Hamilton
Direttore/Membro del Consiglio presso Anaveon AG
Provenienza dei contatti di primo grado di Alex Hamilton
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Oxford
364
| College/University | Other Consumer Services | 364 |
University of Cambridge
239
| College/University | Other Consumer Services | 239 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.
31
| Subsidiary | Investment Managers | 31 |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA.
10
| Private Company | Biotechnology | 10 |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.
9
| Holding Company | Biotechnology | 9 |
Winchester College
3
| College/University | Other Consumer Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alex Hamilton tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Private Equity Investor | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
The World Bank Group
 The World Bank Group SupranationalGovernment Promotes private investments in developing countries | Supranational | Corporate Officer/Principal | |
ECI Partners LLP
 ECI Partners LLP Investment ManagersFinance ECI Partners LLP (ECI Partners) is a private equity founded in 1976. The firm is headquartered in London, the United Kingdom with an additional offices in Manchester and New York. | Investment Managers | Private Equity Investor | |
CBPE Capital LLP
 CBPE Capital LLP Investment ManagersFinance CBPE Capital LLP (CBPE Capital) is a private equity firm founded in 1984. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| The College of New Jersey | College/University | Undergraduate Degree | |
| Queen's University of Belfast | College/University | Undergraduate Degree | |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | Private Equity Investor | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| China Europe International Business School | College/University | Masters Business Admin | |
BlackRock Investment Management (UK) Ltd.
 BlackRock Investment Management (UK) Ltd. Investment ManagersFinance BlackRock Investment Management (UK) Ltd. (BIM-UK) is an investment management firm headquartered in London, UK. The firm is a subsidiary of BlackRock Finance Europe Ltd., ultimately owned by BlackRock, Inc. (NYSE: BLK) in the US. BIM-UK was founded in 2006 following the merger of Merrill Lynch Investment Managers and BlackRock. In 2009, BlackRock merged with Barclays Global Investors, including the iShares exchange traded funds business. The combined firm operates under the BlackRock name and has retained the iShares brand. BIM-UK manages a family of mutual funds and acts as sub-advisor to other mutual and pension funds. They also offer alternative investments and managed accounts for individual and institutional clients. | Investment Managers | Portfolio Manager-Equities | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Atomico (UK) Partners LLP
 Atomico (UK) Partners LLP Investment ManagersFinance Atomico (UK) Partners LLP (Atomico (UK) Partners) is a venture capital firm founded in 2006 by Mattias Ljungman and Niklas Mårten Zennström. The firm is headquartered in London, United Kinghdom with additional offices in Sau Paulo and New York. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| King's College London | College/University | Undergraduate Degree Doctorate Degree | |
| Jiangxi University of Science & Technology | College/University | Director/Board Member | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
McKinsey & Co., Inc. (United Kingdom)
 McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Dev Equity LLC
 Dev Equity LLC Investment ManagersFinance Dev Equity LLC (Dev Equity) is a private equity firm founded in 2005 by Forrest Metz. The firm is headquartered in Tucson, Arizona. | Investment Managers | Consultant / Advisor | |
Agathos Management LLP
 Agathos Management LLP Investment ManagersFinance Agathos Management LLP (Agathos) is an independent private equity firm founded in 2014 by William de Laszlo and Charles Henry Bowdler Oakshett. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
The World Bank (Research)
 The World Bank (Research) Investment ManagersFinance The World Bank (Research) (World Bank-Research) is the investment research division of The World Bank, an international financial institution headquartered in Washington, DC. It provides loans and grants to the governments of low- and middle-income countries for the purpose of pursuing capital projects. World Bank-Research provides research to developing nations to aid economic advancement. | Investment Managers | Economist Economist | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
37 Angels LLC
 37 Angels LLC Investment ManagersFinance 37 Angels LLC (37 Angels) is a venture capital firm founded in 2012 by Angela Lee. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Lockheed Martin Ventures
 Lockheed Martin Ventures Investment ManagersFinance Lockheed Martin Ventures (Lockheed Martin Ventures) is a venture capital subsidiary of Lockheed Martin Corp founded in 2007. The firm is headquartered in Bethesda, Maryland. | Investment Managers | Corporate Officer/Principal | |
| The Boston Consulting Group | Consultant / Advisor Director/Board Member | ||
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Swanbio Therapeutics Ltd.
 Swanbio Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Swanbio Therapeutics Ltd. engages in the research and experimental development of biotechnology. The company was founded on September 1, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Graduate School of Education | College/University | Corporate Officer/Principal | |
Azeria Therapeutics Ltd.
 Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
FoRx Therapeutics AG
 FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
Kilonova Capital LLC
 Kilonova Capital LLC Investment ManagersFinance Kilonova Capital LLC (Kilonova Capital) is a private equity firm founded in 2017 by Mark Watt. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Beyondnetzero
 Beyondnetzero Investment ManagersFinance Beyondnetzero (BNZ) is a private equity firm, a subsidiary of General Atlantic LLC founded in 2021 by Lance Darrell Gordon Uggla and Lord John Browne. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Forcefield Therapeutics Ltd. | Chairman Director/Board Member Chief Executive Officer Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 27 |
| Stati Uniti | 19 |
| Cina | 4 |
| Svizzera | 3 |
| Messico | 2 |
Settori
| Finance | 17 |
| Health Technology | 15 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 258 |
| Corporate Officer/Principal | 122 |
| Private Equity Investor | 79 |
| Undergraduate Degree | 73 |
| Graduate Degree | 59 |
Contatti più connessi
| Insiders | |
|---|---|
| Ran Nussbaum | 38 |
| Martin Murphy | 33 |
| Ken Galbraith | 30 |
| Roel Bulthuis | 29 |
| Alison Lawton | 24 |
| Bryan Geoffrey Morton | 22 |
| Gary Phillips | 20 |
| Chris Hollowood | 19 |
| Thomas Anderson | 17 |
| John Lee Allen | 16 |
| Mweashuma Nyatta | 15 |
| Hitesh Thakrar | 14 |
| David Weiner | 14 |
| Patricia Allen | 14 |
| Anderson Timothy | 13 |
- Borsa valori
- Insiders
- Alex Hamilton
- Connessioni Società
